Suppr超能文献

人类中MDM2癌基因的单倍型结构与选择

Haplotype structure and selection of the MDM2 oncogene in humans.

作者信息

Atwal Gurinder Singh, Bond Gareth L, Metsuyanim Sally, Papa Moshe, Friedman Eitan, Distelman-Menachem Tal, Ben Asher Edna, Lancet Doron, Ross David A, Sninsky John, White Tomas J, Levine Arnold J, Yarden Ronit

机构信息

Institute for Advanced Study, Simons Center for Systems Biology, Princeton, NJ 08540, USA.

出版信息

Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4524-9. doi: 10.1073/pnas.0610998104. Epub 2007 Mar 5.

Abstract

The MDM2 protein is an ubiquitin ligase that plays a critical role in regulating the levels and activity of the p53 protein, which is a central tumor suppressor. A SNP in the human MDM2 gene (SNP309 T/G) occurs at frequencies dependent on demographic history and has been shown to have important differential effects on the activity of the MDM2 and p53 proteins and to associate with altered risk for the development of several cancers. In this report, the haplotype structure of the MDM2 gene is determined by using 14 different SNPs across the gene from three different population samples: Caucasians, African Americans, and the Ashkenazi Jewish ethnic group. The results presented in this report indicate that there is a substantially reduced variability of the deleterious SNP309 G allele haplotype in all three populations studied, whereas multiple common T allele haplotypes were found in all three populations. This observation, coupled with the relatively high frequency of the G allele haplotype in both and Caucasian and Ashkenazi Jewish population data sets, suggests that this haplotype could have undergone a recent positive selection sweep. An entropy-based selection test is presented that explicitly takes into account the correlations between different SNPs, and the analysis of MDM2 reveals a significant departure from the standard assumptions of selective neutrality.

摘要

MDM2蛋白是一种泛素连接酶,在调节p53蛋白的水平和活性方面发挥着关键作用,而p53蛋白是一种核心肿瘤抑制因子。人类MDM2基因中的一个单核苷酸多态性(SNP309 T/G)出现的频率取决于人口统计学历史,并且已被证明对MDM2和p53蛋白的活性有重要的差异影响,并与几种癌症发生风险的改变相关。在本报告中,通过使用来自三个不同人群样本(高加索人、非裔美国人以及德系犹太人族群)的该基因上的14个不同单核苷酸多态性来确定MDM2基因的单倍型结构。本报告中呈现的结果表明,在所研究的所有三个人群中,有害的SNP309 G等位基因单倍型的变异性大幅降低,而在所有三个人群中都发现了多个常见的T等位基因单倍型。这一观察结果,再加上在高加索人和德系犹太人种群数据集中G等位基因单倍型的相对高频率,表明该单倍型可能经历了近期的正向选择扫荡。提出了一种基于熵的选择测试,该测试明确考虑了不同单核苷酸多态性之间的相关性,并且对MDM2的分析揭示了与选择性中性的标准假设存在显著偏差。

相似文献

1
Haplotype structure and selection of the MDM2 oncogene in humans.
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4524-9. doi: 10.1073/pnas.0610998104. Epub 2007 Mar 5.
2
Identification of functional DNA variants in the constitutive promoter region of MDM2.
Hum Genomics. 2012 Sep 1;6(1):15. doi: 10.1186/1479-7364-6-15.
3
Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.
Gene. 2021 Aug 15;793:145747. doi: 10.1016/j.gene.2021.145747. Epub 2021 May 30.
4
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Breast Cancer Res Treat. 2008 Oct;111(3):497-504. doi: 10.1007/s10549-007-9797-z. Epub 2007 Nov 18.
7
Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma.
Mutat Res. 2010 Feb 3;684(1-2):106-8. doi: 10.1016/j.mrfmmm.2009.11.008. Epub 2009 Nov 30.
8
MDM2 SNP309 and SNP354 are not associated with lung cancer risk.
Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1559-61. doi: 10.1158/1055-9965.EPI-06-0217.
9
MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients.
Biomarkers. 2011 Feb;16(1):42-50. doi: 10.3109/1354750X.2010.525664. Epub 2010 Oct 28.

引用本文的文献

1
Molecular signatures of breast cancer in the Iranian population: a review of cell growth and cell cycle regulators.
J Cancer Res Clin Oncol. 2025 Sep 11;151(9):255. doi: 10.1007/s00432-025-06301-y.
3
Gene-level quantitative trait mapping in Caenorhabditis elegans.
G3 (Bethesda). 2021 Feb 9;11(2). doi: 10.1093/g3journal/jkaa061.
4
The role of p53 in reproduction, an unexpected function for a tumor suppressor.
J Mol Cell Biol. 2019 Jul 19;11(7):624-627. doi: 10.1093/jmcb/mjz072.
6
Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome.
PLoS One. 2016 Nov 29;11(11):e0167147. doi: 10.1371/journal.pone.0167147. eCollection 2016.
7
8
Genetic Variations in the TP53 Pathway in Native Americans Strongly Suggest Adaptation to the High Altitudes of the Andes.
PLoS One. 2015 Sep 18;10(9):e0137823. doi: 10.1371/journal.pone.0137823. eCollection 2015.
10
Polymorphism of genes and implantation failure.
Int J Mol Cell Med. 2013 Winter;2(1):1-8.

本文引用的文献

2
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C.
Clin Cancer Res. 2006 Aug 15;12(16):4867-71. doi: 10.1158/1078-0432.CCR-06-0111.
3
MDM2 309T>G polymorphism and risk of lung cancer in a Korean population.
Lung Cancer. 2006 Oct;54(1):19-24. doi: 10.1016/j.lungcan.2006.06.008. Epub 2006 Jul 27.
4
MDM2 SNP309 accelerates colorectal tumour formation in women.
J Med Genet. 2006 Dec;43(12):950-2. doi: 10.1136/jmg.2006.043539. Epub 2006 Jul 6.
5
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.
Cancer Res. 2006 May 15;66(10):5104-10. doi: 10.1158/0008-5472.CAN-06-0180.
6
Polymorphic variants in the p53 pathway.
Cell Death Differ. 2006 Jun;13(6):916-20. doi: 10.1038/sj.cdd.4401907.
8
A map of recent positive selection in the human genome.
PLoS Biol. 2006 Mar;4(3):e72. doi: 10.1371/journal.pbio.0040072. Epub 2006 Mar 7.
9
Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.
J Natl Cancer Inst. 2006 Feb 15;98(4):285-8. doi: 10.1093/jnci/djj054.
10
No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites.
Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):175-7. doi: 10.1158/1055-9965.EPI-05-0692.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验